Cargando…
Rates of False-Negative Screening in Prostate Specific Antigen Secondary to 5-Alpha Reductase Inhibitor Usage: A Quality-Improvement Initiative
PURPOSE: Patients often take 5-alpha reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia. However, 5-ARIs can decrease prostate specific antigen (PSA) by approximately half and therefore may lead to false negative PSA tests. We investigated false-screening rates in men o...
Autores principales: | Loloi, Justin, Wei, Matthew, Babar, Mustufa, Zhu, Denzel, Fram, Ethan B., Maria, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306367/ https://www.ncbi.nlm.nih.gov/pubmed/35594325 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.0099 |
Ejemplares similares
-
Nanotechnology as a tool to advance research and treatment of
non-oncologic urogenital diseases
por: Loloi, Justin, et al.
Publicado: (2022) -
TikTok as a source of information regarding premature ejaculation: a qualitative assessment
por: Bernstein, Ari, et al.
Publicado: (2023) -
False-negative synovial alpha-defensin
por: Adams, Jake R., et al.
Publicado: (2017) -
5-alpha-reductase and the development of the human prostate
por: Radmayr, C., et al.
Publicado: (2008) -
Factors associated with false negative and false positive results of prostate-specific antigen (PSA) and the impact on patient health: Cohort study protocol
por: Bernal-Soriano, Mari Carmen, et al.
Publicado: (2019)